logo
Select company
Select metric
$ 358.25MWorking Capital
VS
Market
73
Sector
79
Industry
83
History
77
$ 9.84Close
$ 8.24 - $ 28.14 52-Week Range
Ticker Information

Ticker

NRIX

Company Name

NURIX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NURIX THERAPEUTICS INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRIX - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
9/30/2025$ 440.6M$ 82.35M$ 358.25M
6/30/2025$ 515.33M$ 75.61M$ 439.72M
3/31/2025$ 563.7M$ 89.99M$ 473.71M
12/31/2024$ 619.39M$ 95.85M$ 523.53M
9/30/2024$ 456.04M$ 86.3M$ 369.75M
6/30/2024$ 450.22M$ 80.78M$ 369.44M
3/31/2024$ 250.97M$ 87.62M$ 163.35M
12/31/2023$ 295.5M$ 86.96M$ 208.54M
9/30/2023$ 267.95M$ 61.49M$ 206.46M
6/30/2023$ 290.01M$ 72.26M$ 217.75M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NURIX THERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ 253.9M.
  • Over the past 5 years, NURIX THERAPEUTICS INC's average Working Capital has been $ 297.82M.
  • The median Working Capital for NURIX THERAPEUTICS INC during this period was $ 258.35M
  • NURIX THERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ 523.53M.
  • The lowest Working Capital recorded by NURIX THERAPEUTICS INC in the same timeframe $ 163.35M

NURIX THERAPEUTICS INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
SNDX : SYNDAX PHARMACEUTICALS INC $ 418.69MURGN : UROGEN PHARMA LTD $ 149.32MTBPH : THERAVANCE BIOPHARMA INC $ 311.66MKURA : KURA ONCOLOGY INC $ 552.9MGYRE : GYRE THERAPEUTICS INC $ 74.36MZVRA : ZEVRA THERAPEUTICS INC $ 197.5MCRMD : CORMEDIX INC $ 216.35MNAGE : NIAGEN BIOSCIENCE INC $ 64.35MSAGE : SAGE THERAPEUTICS INC $ 364.44MEYPT : EYEPOINT PHARMACEUTICALS INC $ 232.08M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for NURIX THERAPEUTICS INC is calculated as follows: AssetsC [ $ 298.43M ] - LiabilitesC [ $ 44.54M ]
(=) Working Capital [ $ 253.9M ]

NRIX - Working Capital, Last 5 years

$ 163.35M

Minimum

Mar 31, 2024

$ 523.53M

Maximum

Dec 31, 2024

$ 297.82M

Average

$ 258.35M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.42M with a standard deviation of $ 173.65M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.79K
min$ -457.39M
max$ 607.04M
average$ 96.42M
median$ 32.11M
std$ 173.65M